A. M. Thirugnanam/LinkedIn
Sep 18, 2026, 15:01
A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis
A. M. Thirugnanam, Senior Interventional Cardiologist at Kamineni Hospital, India, shared a post on LinkedIn:
“Premature antiplatelet discontinuation remains one of the most preventable causes of stent thrombosis, and it is very often triggered by well meaning advice from outside cardiology before a minor procedure.
Worth sharing with patients and with colleagues who schedule dental and endoscopic work.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 14:52Abdul Muqtadir Abbasi: How Do Hematologists Know Which Coagulation Factor Is the Problem?
-
Sep 18, 2026, 14:48Kato Ramaekers: Redefining Integrin αIIbβ3 in Platelet Formation
-
Sep 18, 2026, 14:33Heghine Khachatryan: The discussion of Thrombophilia, APS and Coagulation Testing
-
Sep 18, 2026, 14:27Maria Cherska: Are We Overlooking the Spleen in Cardiometabolic Research?
-
Sep 18, 2026, 14:05Wolfram Ruf: Managing Thrombotic Risk in Pregnancy
-
Sep 18, 2026, 13:38Sam Tsimikas: Uncovering a Modifiable Lp(a) Phenotype in Hypertriglyceridemia
-
Sep 18, 2026, 13:22Christine Rabinak: Predictive Modeling for Individualized Unfractionated Heparin Dosing
-
Sep 18, 2026, 13:07Bastu Odoka: Principles of Pediatric Transfusion Dosing
-
Sep 18, 2026, 12:54David McIntosh: Plasma Therapies and the Unfinished Global Access Mission